ClinicalTrialsFinder

Metastatic Prostate Adenocarcinoma With Neuroendocrine Differentiation Clinical Trials in Chicago, Illinois

1 recruitingChicago, Illinois

Showing 1–1 of 1 trials

Recruiting
Phase 2

Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells

Stage IV Prostate Cancer AJCC v8Metastatic Prostate Small Cell Neuroendocrine CarcinomaMetastatic Prostate Adenocarcinoma With Neuroendocrine Differentiation+1 more
National Cancer Institute (NCI)30 enrolled13 locationsNCT05691465